Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH

An active comparator was present in 95% of the 337 analysed reports; 50% included a direct comparative study vs comparator. In 114 reports (34%), an IC was used; 69% of the ICs were made by the report author. Most ICs were narrative and none were adjusted. An IC could have been made in an additio...

Full description

Bibliographic Details
Main Authors: Ortega-Eslava, A. (Ana), Fraga-Fuentes, M.D. (M.D.), Puigventos, F. (Francesc), Santos-Ramos, B. (B.), Clopes-Estela, A. (A.), Vilanova-Bolto, M. (M.)
Format: info:eu-repo/semantics/article
Language:spa
Published: Elsevier 2012
Subjects:
Online Access:https://hdl.handle.net/10171/22957
_version_ 1793400199075332096
author Ortega-Eslava, A. (Ana)
Fraga-Fuentes, M.D. (M.D.)
Puigventos, F. (Francesc)
Santos-Ramos, B. (B.)
Clopes-Estela, A. (A.)
Vilanova-Bolto, M. (M.)
author_facet Ortega-Eslava, A. (Ana)
Fraga-Fuentes, M.D. (M.D.)
Puigventos, F. (Francesc)
Santos-Ramos, B. (B.)
Clopes-Estela, A. (A.)
Vilanova-Bolto, M. (M.)
author_sort Ortega-Eslava, A. (Ana)
collection DSpace
description An active comparator was present in 95% of the 337 analysed reports; 50% included a direct comparative study vs comparator. In 114 reports (34%), an IC was used; 69% of the ICs were made by the report author. Most ICs were narrative and none were adjusted. An IC could have been made in an additional 16% of the cases and possibly in 24% more. Conclusions: Most evaluated drugs have an active comparator but studies comparing them directly are not as common. ICs could be included in more reports along with quality control criteria. © 2011 SEFH. Published
format info:eu-repo/semantics/article
id oai:dadun.unav.edu:10171-22957
institution Universidad de Navarra
language spa
publishDate 2012
publisher Elsevier
record_format dspace
spelling oai:dadun.unav.edu:10171-229572020-03-04T02:21:42Z Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH Ortega-Eslava, A. (Ana) Fraga-Fuentes, M.D. (M.D.) Puigventos, F. (Francesc) Santos-Ramos, B. (B.) Clopes-Estela, A. (A.) Vilanova-Bolto, M. (M.) Indirect comparisons Decision-making Drug evaluation An active comparator was present in 95% of the 337 analysed reports; 50% included a direct comparative study vs comparator. In 114 reports (34%), an IC was used; 69% of the ICs were made by the report author. Most ICs were narrative and none were adjusted. An IC could have been made in an additional 16% of the cases and possibly in 24% more. Conclusions: Most evaluated drugs have an active comparator but studies comparing them directly are not as common. ICs could be included in more reports along with quality control criteria. © 2011 SEFH. Published 2012-07-30T11:22:45Z 2012-07-30T11:22:45Z 2012 info:eu-repo/semantics/article https://hdl.handle.net/10171/22957 spa info:eu-repo/semantics/openAccess application/pdf Elsevier
spellingShingle Indirect comparisons
Decision-making
Drug evaluation
Ortega-Eslava, A. (Ana)
Fraga-Fuentes, M.D. (M.D.)
Puigventos, F. (Francesc)
Santos-Ramos, B. (B.)
Clopes-Estela, A. (A.)
Vilanova-Bolto, M. (M.)
Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH
title Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH
title_full Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH
title_fullStr Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH
title_full_unstemmed Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH
title_short Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH
title_sort comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo genesis de la sefh
topic Indirect comparisons
Decision-making
Drug evaluation
url https://hdl.handle.net/10171/22957
work_keys_str_mv AT ortegaeslavaaana comparacionesindirectasenlosinformesdeevaluaciondemedicamentosenlawebdelgrupogenesisdelasefh
AT fragafuentesmdmd comparacionesindirectasenlosinformesdeevaluaciondemedicamentosenlawebdelgrupogenesisdelasefh
AT puigventosffrancesc comparacionesindirectasenlosinformesdeevaluaciondemedicamentosenlawebdelgrupogenesisdelasefh
AT santosramosbb comparacionesindirectasenlosinformesdeevaluaciondemedicamentosenlawebdelgrupogenesisdelasefh
AT clopesestelaaa comparacionesindirectasenlosinformesdeevaluaciondemedicamentosenlawebdelgrupogenesisdelasefh
AT vilanovaboltomm comparacionesindirectasenlosinformesdeevaluaciondemedicamentosenlawebdelgrupogenesisdelasefh